{
    "clinical_study": {
        "@rank": "11688", 
        "arm_group": [
            {
                "arm_group_label": "soy protein isolate (SPI)", 
                "arm_group_type": "Experimental", 
                "description": "25 grams soy protein isolate (SPI) containing approximately 30 mg/d isoflavones"
            }, 
            {
                "arm_group_label": "milk protein isolate (MPI)", 
                "arm_group_type": "Active Comparator", 
                "description": "milk protein isolate (MPI) containing 0 mg/d isoflavones"
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to help the researchers understand if using a soy supplement\n      impacts cardiovascular disease risk factors in patients with subclinical hypothyroidism."
        }, 
        "brief_title": "Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants", 
        "completion_date": {
            "#text": "August 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Cardiovascular Disease", 
            "Subclinical Hypothyroid"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Cardiovascular Diseases", 
                "Hypothyroidism"
            ]
        }, 
        "detailed_description": {
            "textblock": "This pilot trial is a double blind, randomized, parallel arm trial. Eighty participants with\n      subclinical hypothyroidism will be randomized to consume either soy protein isolate  or milk\n      protein isolate for 8 weeks."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with subclinical hypothyroidism (otherwise healthy volunteers)\n\n          -  Adults aged 25 - 70 yrs.\n\n          -  Willing to avoid consumption of soy/other isoflavone containing foods (i.e. some\n             snack bars) during the study.\n\n          -  Willing to avoid consumption of dietary (other than multivitamin) and herbal\n             supplements during the study.\n\n        Exclusion Criteria:\n\n          -  Taking drugs that interfere with thyroid function\n\n          -  Planning pregnancy in the next 6 months\n\n          -  Taking drugs that lower lipids, blood pressure, or sensitize insulin\n\n          -  Regular consumption of soy products (>20 g/wk)\n\n          -  Consumption of soyfoods within 90 days prior to enrollment.\n\n          -  Known history of soy or milk allergy or intolerance.\n\n          -  Taking antibiotics during the intervention\n\n          -  Active viral infections such as Human immunodeficiency virus (HIV) positive or\n             hepatitis"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "70 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "80", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "December 27, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02024906", 
            "org_study_id": "STUDY00000073", 
            "secondary_id": [
                "UL1TR000001", 
                "HD002528"
            ]
        }, 
        "intervention": [
            {
                "arm_group_label": "soy protein isolate (SPI)", 
                "intervention_name": "soy protein isolate (SPI)", 
                "intervention_type": "Dietary Supplement"
            }, 
            {
                "arm_group_label": "milk protein isolate (MPI)", 
                "intervention_name": "milk protein isolate (MPI)", 
                "intervention_type": "Dietary Supplement"
            }
        ], 
        "is_fda_regulated": "No", 
        "keyword": [
            "isoflavone", 
            "CVD", 
            "soy intake", 
            "subclinical hypothyroid"
        ], 
        "lastchanged_date": "May 19, 2014", 
        "location": {
            "contact": {
                "email": "jhamilton-reeves@kumc.edu", 
                "last_name": "Jill Hamilton-Reeves, PhD, RD, LD", 
                "phone": "913-588-7650"
            }, 
            "facility": {
                "address": {
                    "city": "Kansas City", 
                    "country": "United States", 
                    "state": "Kansas", 
                    "zip": "66160"
                }, 
                "name": "University of Kansas Medical Center"
            }, 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "Effect of Soy Intake on Cardiovascular Disease Biomarkers in Subclinical Hypothyroid Participants", 
        "overall_official": {
            "affiliation": "University of Kansas", 
            "last_name": "Jill Hamilton-Reeves, PhD, RD, LD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "May 2015", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Evaluate the role of isoflavone intake on cardiovascular disease.", 
            "measure": "Changes in the cardiometabolic profile", 
            "safety_issue": "No", 
            "time_frame": "Change from Baseline to Week 8"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02024906"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Kansas Medical Center Research Institute", 
            "investigator_full_name": "Jill Hamilton-Reeves, PhD RD LD", 
            "investigator_title": "Assistant Professor", 
            "responsible_party_type": "Sponsor-Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Safety will be monitored through measuring thyroid stimulating hormone (TSH) and free thyroxine (T4) in participants while on the study.", 
                "measure": "Change in thyroid function", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Basesline to 8 Weeks"
            }, 
            {
                "description": "Safety will be monitored through measuring thyroid stimulating hormone (TSH) and free thyroxine (T4) in participants while on the study.", 
                "measure": "Change in thyroid function", 
                "safety_issue": "Yes", 
                "time_frame": "Change from Basesline to 4 Weeks"
            }, 
            {
                "description": "Evaluate the role of isoflavone intake on cardiovascular disease.", 
                "measure": "Changes in the cardiometabolic profile", 
                "safety_issue": "No", 
                "time_frame": "Change from Basesline to 4 Weeks"
            }
        ], 
        "source": "University of Kansas", 
        "sponsors": {
            "collaborator": {
                "agency": "Soy Nutrition Institute", 
                "agency_class": "Other"
            }, 
            "lead_sponsor": {
                "agency": "Jill Hamilton-Reeves, PhD RD LD", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "August 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "May 2014"
    }
}